Capital Goods Healthcare Sector

Street Capital

Market Cap: CA$1.4m

Focuses on the production and sale of cannabis-based hashish and other cannabis products in Canada.

Psyence Group

Market Cap: CA$1.4m

A life science biotechnology company, engages in the cultivation and production of commercial psilocybin mushroom.

Trevena

Market Cap: US$1.0m

A biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders.

Braxia Scientific

Market Cap: CA$1.4m

Operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders.

Terranueva

Market Cap: CA$1.4m

Terranueva Corporation intends to produce cannabis for medical and recreational purposes.

CBD of Denver

Market Cap: US$980.9k

Engages in developing and commercializing cannabidiol (CBD) products.

Waverley Pharma

Market Cap: CA$1.4m

A biopharmaceutical company, researches, develops, and commercializes oncology therapeutics in the United Kingdom, European Union and North America.

Adastra Holdings

Market Cap: CA$1.3m

Adastra Holdings Ltd. extracts and processes cannabis for recreational and medical markets in Canada.

Wellfully

Market Cap: AU$1.5m

Wellfully Limited, together with its subsidiaries, focuses on the development and commercialization of Dermaportation and ETP transdermal drug delivery technologies.

NovelStem International

Market Cap: US$937.6k

A development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy.

Brain Scientific

Market Cap: US$932.0k

Brain Scientific Inc., a medtech company, provides neurology and motion products in the United States and internationally.

Justera Health

Market Cap: CA$1.2m

Operates as a health and wellness management company in Canada.

WOWI

Market Cap: US$900.0k

An early-stage company, engages in the business of licensing technology and intellectual property to operators and businesses in the legal cannabis industry in the United States.

International Stem Cell

Market Cap: US$880.5k

A clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally.

EV Biologics

Market Cap: US$880.4k

A biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics.

Lifeline Biotechnologies

Market Cap: US$869.8k

Operates as a medical technology company in the United States.

RAMM Pharma

Market Cap: CA$1.2m

Engages in the pharmaceutical and medical product business in Uruguay, Italy, and Poland.

Rimrock Gold

Market Cap: US$865.2k

Through its subsidiary, focuses on the development and marketing a line of CBD oils, creams, and hemp extracts.

ViaDerma

Market Cap: US$863.6k

Operates as a specialty pharmaceutical company in the United States.

Pharmagreen Biotech

Market Cap: US$862.7k

Operates as a nutraceutical company, engages in the formulating products from blends of therapeutic plants and fungi in North America.

Dynatronics

Market Cap: US$861.2k

A medical device company, designs, develops, manufactures, markets, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States, Asia, Latin America, the Middle East, and internationally.

NanoVibronix

Market Cap: US$850.4k

Through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing, and administration at home without the assistance of medical professionals.

SCWorx

Market Cap: US$847.6k

Engages in the provision of data content and services related to the repair, normalization and interoperability of information for healthcare providers in the United States.

Hepion Pharmaceuticals

Market Cap: US$840.2k

A biopharmaceutical company, focuses on the development of treatment for hepatocellular carcinoma (HCC) and other chronic liver diseases in the United States.

Syros Pharmaceuticals

Market Cap: US$833.1k

A biopharmaceutical company, focuses on the development of treatment for hematologic malignancies.

Emmaus Life Sciences

Market Cap: US$830.3k

A commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally.

SQZ Biotechnologies

Market Cap: US$825.8k

A clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions.

MediXall Group

Market Cap: US$800.9k

Provides health solutions in the United States.

Optimind Pharma

Market Cap: CA$1.1m

Provides psychedelic therapies in Canada.

LadRx

Market Cap: US$787.2k

A biopharmaceutical company, engages in research and development of chemotherapeutic drugs for solid tumors in the United States.

Pharmadrug

Market Cap: CA$1.1m

Operates as a specialty pharmaceutical company.

Panacea Life Sciences Holdings

Market Cap: US$776.8k

Operates as a holding company, develops, manufactures, research, produces, and distributes hemp-derived cannabinoid, functional mushroom, Kratom, plant-based ingredients, and nutraceutical products for consumers and pets.

Grapefruit USA

Market Cap: US$774.7k

Operates as a manufacturer and distributor of cannabis products in California.

Ovation Science

Market Cap: CA$1.1m

Engages in the production, sub-licensing, and sale of cannabis or hemp products in Canada and the United States.

Tevano Systems Holdings

Market Cap: CA$1.0m

A technology holding company, engages in the development and operation of software and online applications.

UA Multimedia

Market Cap: US$749.0k

A media company, engages in Web, mobile applications, and film production and distribution activities.